Status:
COMPLETED
Analgesia After Knee Arthroscopy :Dexmedetomidine vs Fentanyl
Lead Sponsor:
Zagazig University
Conditions:
Analgesia
Eligibility:
All Genders
21-45 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate analgesic effects Bupivacaine, Bupivacaine plus Dexmedetomidine and Bupivacaine plus Fentanyl in relieving pain after knee arthroscopic surgery.
Detailed Description
Forty-five patients ASA I - II aged 21-45 years for elective knee arthroscopy were divided into 3 groups: Group B, BD and BF. Group B received Intra-articular injection of 20 ml bupivacaine 0.25%+ 1 m...
Eligibility Criteria
Inclusion
- Either sex,
- Age 21-45 years,
- American Society of Anesthesia (ASA) I - II for elective knee arthroscopy.
Exclusion
- The patients with history of hepatic and renal diseases, psychiatric disorders,
- Prolonged intake of (NSAIDS, opioids and tricyclic antidepressant),
- Allergy to study drugs and patient who received analgesics up to 24 hr. before surgery were excluded from this study.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04442906
Start Date
July 1 2020
End Date
December 1 2020
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig university
Zagazig, Egypt